
A J&J subsidiary’s second Chapter 11 with an $8.9 billion offer to settle cancer claims stunned many interested parties, but it was a product of weeks of hustling, out-of-court talks and a nationwide search for victim lawyers willing to cut a deal.
news.bloomberglaw.com/bankruptcy-law…
English





